Some studies in HNSCC have shown that tumors with HER3 overexpression, mainly localized at the cytoplasmic membrane, have a poorer prognosis [8–11], while de Vicente et al. [12] did not report any correlation between survival and HER3 expression. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.